Adicet Bio Statistics
Total Valuation
Adicet Bio has a market cap or net worth of $57.11 million. The enterprise value is -$56.41 million.
Important Dates
The last earnings date was Thursday, August 7, 2025, before market open.
Earnings Date | Aug 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Adicet Bio has 83.25 million shares outstanding. The number of shares has increased by 42.22% in one year.
Current Share Class | 83.25M |
Shares Outstanding | 83.25M |
Shares Change (YoY) | +42.22% |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | 1.66% |
Owned by Institutions (%) | 40.67% |
Float | 61.92M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.40 |
P/TBV Ratio | 0.40 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.48, with a Debt / Equity ratio of 0.12.
Current Ratio | 7.48 |
Quick Ratio | 7.32 |
Debt / Equity | 0.12 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -63,086.50 |
Financial Efficiency
Return on equity (ROE) is -64.39% and return on invested capital (ROIC) is -39.14%.
Return on Equity (ROE) | -64.39% |
Return on Assets (ROA) | -36.52% |
Return on Invested Capital (ROIC) | -39.14% |
Return on Capital Employed (ROCE) | -86.48% |
Revenue Per Employee | n/a |
Profits Per Employee | -$780,500 |
Employee Count | 152 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.83% in the last 52 weeks. The beta is 1.61, so Adicet Bio's price volatility has been higher than the market average.
Beta (5Y) | 1.61 |
52-Week Price Change | -47.83% |
50-Day Moving Average | 0.71 |
200-Day Moving Average | 0.84 |
Relative Strength Index (RSI) | 45.44 |
Average Volume (20 Days) | 515,550 |
Short Selling Information
The latest short interest is 4.03 million, so 4.84% of the outstanding shares have been sold short.
Short Interest | 4.03M |
Short Previous Month | 3.76M |
Short % of Shares Out | 4.84% |
Short % of Float | 6.51% |
Short Ratio (days to cover) | 10.09 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -126.17M |
Pretax Income | -139.79M |
Net Income | -118.64M |
EBITDA | -119.62M |
EBIT | -126.17M |
Earnings Per Share (EPS) | -$1.30 |
Full Income Statement Balance Sheet
The company has $124.96 million in cash and $15.36 million in debt, giving a net cash position of $109.61 million or $1.32 per share.
Cash & Cash Equivalents | 124.96M |
Total Debt | 15.36M |
Net Cash | 109.61M |
Net Cash Per Share | $1.32 |
Equity (Book Value) | 133.37M |
Book Value Per Share | 1.60 |
Working Capital | 110.66M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$98.14 million and capital expenditures -$2.12 million, giving a free cash flow of -$100.25 million.
Operating Cash Flow | -98.14M |
Capital Expenditures | -2.12M |
Free Cash Flow | -100.25M |
FCF Per Share | -$1.20 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Adicet Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -42.22% |
Shareholder Yield | -42.22% |
Earnings Yield | -223.00% |
FCF Yield | -188.45% |
Dividend Details Analyst Forecast
The average price target for Adicet Bio is $5.60, which is 716.33% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $5.60 |
Price Target Difference | 716.33% |
Analyst Consensus | Strong Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | -37.97% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |